Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Symbicort BA MDI versus Symbicort AC pMDI and budesonide AC pMDI in adolescent and adult asthma
2011-002523-17Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Jul 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of budesonide in asthma (3 arms), sponsored by AstraZeneca. Primary endpoint: Forced expiratory volume in 1 second (FEV1). Started Jul 2011; status: completed.
02
Drugs
budesonide
03
Conditions
asthma
Beyond the preview
Go deeper on 2011-002523-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002523-17.